Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma
- 12 October 2019
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 520 (3), 544-550
- https://doi.org/10.1016/j.bbrc.2019.10.052
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31571336)
This publication has 32 references indexed in Scilit:
- A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinomaOncotarget, 2015
- CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast CancerCell, 2015
- Refining the treatment of NSCLC according to histological and molecular subtypesNature Reviews Clinical Oncology, 2015
- Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencingHuman Molecular Genetics, 2015
- Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 InhibitorCancer Cell, 2014
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven CancerCell, 2014
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitorNature, 2014
- Super-Enhancers in the Control of Cell Identity and DiseaseCell, 2013
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genesGenes & Development, 2011
- CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1Genes & Development, 2010